S. Li

963 citations
23 papers · 699 · h-index 8

Impact in

  • Immunology top 5%
    • Psoriasis: Treatment and Pathogenesis
    • Immunodeficiency and Autoimmune Disorders
  • Dermatology top 2%
    • Dermatology and Skin Diseases

Papers in

Co-authors
Yasmine Wasfi (5 shared papers)B. Randazzo (5 shared papers)Michael Song (6 shared papers)Tsen‐Fang Tsai (2 shared papers)L. Puig (5 shared papers)Richard G. Langley (1 shared paper)Susan Flavin (1 shared paper)Jingzhi Jiang (1 shared paper)
Journals
British Journal of Dermatology (5 papers)Annals of the Rheumatic Diseases (5 papers)Annals of Oncology (3 papers)Journal of the European Academy of Dermatology and Venereology (2 papers)BMJ Open (2 papers)
Partner nations
United StatesCanadaChina

In The Last Decade

S. Li

23 papers receiving 685 citations

Peers

S. Li
Comparison fields: 5 of 50
  • Immunology 569
  • Dermatology 206
  • Rheumatology 103
  • Hematology 71
  • Physiology 99
Replace Jeffrey Zweegers with:
Jeffrey Zweegers Netherlands
S.P. Menting Netherlands
Miriam Teoli Italy
Jeff Gulcher Iceland
Perla Lansang Canada
Dafna Gladman Canada
A. Howland Hartley United States
Drew J.B. Kurtzman United States
Alexander Marsland United Kingdom
Jason Coarse United States
S. Li relative to Jeffrey Zweegers Netherlands Jeffrey Zweegers's profile →
Citations per field
00.5×2×2.8×
Jeffrey Zweegers · 1×
Citations per year

Countries citing papers authored by S. Li

Since Specialization
Citations

This map shows the geographic impact of S. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Li more than expected).

Fields of papers citing papers by S. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Li. The network helps show where S. Li may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Li Line = papers co-authored together S. Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial
British Journal of Dermatology ·Richard G. Langley, Tsen‐Fang Tsai, Susan Flavin, Michael Song, B. Randazzo, Yasmine Wasfi, Jingzhi Jiang, S. Li, L. Puig
2017248
2
Long‐term efficacy of ustekinumab in patients with moderate‐to‐severe psoriasis treated for up to 5 years in the PHOENIX 1 study
Journal of the European Academy of Dermatology and Venereology ·Alexa B. Kimball, Kim Papp, Yasmine Wasfi, Daphne Chan, Robert Bissonnette, Howard Sofen, Newman Yeilding, S. Li, Philippe Szapary, Kenneth B. Gordon, (unknown)
2012164
3
The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection
British Journal of Dermatology ·Tsen‐Fang Tsai, Vincent Ho, Michael Song, Philippe Szapary, Takeshi Kato, Yasmine Wasfi, S. Li, Yaung‐Kaung Shen, C. Leonardi, (unknown), (unknown)
201265
4
Safety of guselkumab in patients with moderate‐to‐severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies
British Journal of Dermatology ·Kristian Reich, Kim Papp, April W. Armstrong, Yasmine Wasfi, S. Li, Yaung‐Kaung Shen, B. Randazzo, Michael Song, Alexa B. Kimball
201854
5
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study
British Journal of Dermatology ·Sandra Philipp, Alan Menter, Arjen Nikkels, K. Barber, Ian Landells, Lawrence F. Eichenfield, Michael Song, B. Randazzo, S. Li, Ming‐Chen Hsu, Yaowei Zhu, Samuel E. DePrimo, Amy S. Paller
202053
6
Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a phase IIIb, randomized, double-blinded, active-controlled, multicentre study (PSTELLAR)
British Journal of Dermatology ·Andrew Blauvelt, Laura K. Ferris, Paul S. Yamauchi, Abrar A. Qureshi, C. Leonardi, Kamyar Farahi, Steven Fakharzadeh, Ming-Chun Hsu, S. Li, Marc Chévrier, Kevin S. Smith, Kavitha Goyal, Yanqing Chen, Ernesto J. Muñoz‐Elías, Kristina Callis Duffin
201746
7
Patient‐reported symptoms and signs of moderate‐to‐severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial
Journal of the European Academy of Dermatology and Venereology ·Kim Papp, Andrew Blauvelt, Alexa B. Kimball, Chenglong Han, B. Randazzo, Yasmine Wasfi, Yaung‐Kaung Shen, S. Li, C.E.M. Griffiths
201818
8
OP0158 Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit I study
Annals of the Rheumatic Diseases ·Iain B. McInnes, Arthur Kavanaugh, A.B. Gottlieb, L. Puig, Proton Rahman, Christopher T. Ritchlin, S. Li, Y. Wang, Alan M. Mendelsohn, Mittie K. Doyle
201217
9
Bibliometric analysis of neuroinflammation and Alzheimer’s disease
Frontiers in Aging Neuroscience ·Wenxian Sun, Jin Gong, S. Li, Wang Pin, Xiaodong Han, Xu Chang, Heya Luan, Ruina Li, Boye Wen, Cuibai Wei
20246
10
451 Association between HLA-Cw6 status and response to guselkumab in patients with moderate to severe plaque psoriasis
Journal of Investigative Dermatology ·X. Liu, Samuel E. DePrimo, Y. Chen, S. Li, Ernesto J. Muñoz‐Elías
20184
11
LATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT+abiraterone acetate and prednisone (AAP) or placebo (PBO)
Annals of Oncology ·Nobuaki Matsubara, K.N. Chi, Mustafa Özgüroğlu, A. Rodrı́guez-Antolı́n, Susan Feyerabend, Luis Fein, B. Yа. Alekseev, G. Sulur, Andrew Protheroe, S. Li, Suneel Mundle, Peter De Porre, NamPhuong Tran, K. Fazazi
20184
12
Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study)
BMJ Open ·Pei Wang, Wenxian Sun, Jin Gong, Xiaodong Han, Chang Xu, Yufei Chen, Yuting Yang, Heya Luan, S. Li, Ruina Li, Boye Wen, Sirong Lv, Cuibai Wei
20243
13
632P Health-related quality of life (HRQoL) at final analysis of the SPARTAN study of apalutamide (APA) vs placebo (PBO) in patients (pts) with non-metastatic castration-resistant prostate cancer (nmCRPC) receiving androgen deprivation therapy (ADT)
Annals of Oncology ·Stéphane Oudard, Boris Hadaschik, Fred Saad, David Cella, Ethan Basch, Paul N. Mainwaring, Julie N. Graff, Shiva Dibaj, S. Li, S. Brookman-May, Peter De Porre, Jeremiah Trudeau, Eric J. Small, Mitchell R. Smith
20203
14
Efficacy and safety of DL‐3‐n‐butylphthalide in patients with mild cognitive impairment: a multicentre, randomized, double‐blind, placebo‐controlled trial
Alzheimer s & Dementia ·Pei Wang, Wenxian Sun, Jin Gong, Xiaodong Han, Chang Xu, Yufei Chen, Yuting Yang, Heya Luan, S. Li, Ruina Li, Boye Wen, Sirong Lv, Cuibai Wei
20242
15
SAT0563 Long Term Improvements in Physical Function are Associated with Improvements in Dactylitis, Enthesitis, Tender and Swollen Joint Counts, and Psoriasis Skin Involvement: Results from a Phase 3 Study of Ustekinumab in Psoriatic Arthritis Patients
Annals of the Rheumatic Diseases ·Arthur Kavanaugh, L. Puig, Alice B. Gottlieb, Christopher T. Ritchlin, S. Li, Yin You, Alan M. Mendelsohn, Michael Song, Proton Rahman, Iain B. McInnes
20152
16
THU0419 Integrated Safety of Ustekinumab in Psoriatic Arthritis: 2 Year Follow-Up from the Psoriatic Arthritis Clinical Development Program
Annals of the Rheumatic Diseases ·Arthur Kavanaugh, Iain B. McInnes, Christopher T. Ritchlin, Proton Rahman, L. Puig, Alice B. Gottlieb, Michael Song, B. Randazzo, S. Li, Yin You, Alan M. Mendelsohn
20152
17
The Impact of Abiraterone Acetate (AA) Therapy on Patient-Reported Pain and Functional Status in Chemotherapy-Naive Patients with Progressive, Metastatic Castration-Resistant Prostate Cancer (MCRPC)
Annals of Oncology ·Ethan Basch, Charles J. Ryan, Thian Kheoh, Karim Fizazi, C. Logothetis, Dana E. Rathkopf, Mitchell R. Smith, Paul N. Mainwaring, Yanni Hao, Thomas W. Griffin, S. Li, Michael L. Meyers, A. Molina, Charles S. Cleeland
20122
18
Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double‐blind, placebo‐controlled trial
Psychiatry and Clinical Neurosciences ·Xiaodong Han, Shuting Gong, Jin Gong, Pei Wang, Ruina Li, Runqi Chen, Chang Xu, Wenxian Sun, S. Li, Yufei Chen, Yuting Yang, Heya Luan, Boye Wen, Jinxuan Guo, Sirong Lv, Cuibai Wei
20251
19
VSIG4 as a tumor-associated macrophage marker predicting adverse prognosis in diffuse large B-cell lymphoma
Frontiers in Immunology ·Dongshen Ma, Yubo Wang, Qingqing Shen, Xinyu Liu, Wenxin Lu, S. Li, Qianqian Yin, Lei Xia, Guangzhen Liu, Yu‐Hong Chen, Chenxi Xiang, Hui Liu
20251
20
Extensive perivascular spaces burden causally affects neurodegenerative diseases and brain structure: A two-sample bidirectional Mendelian randomization study
Progress in Neuro-Psychopharmacology and Biological Psychiatry ·(unknown), Heya Luan, S. Li, Xiaodong Han, Wenxian Sun, Jin Gong, Chang Xu, Runqi Chen, Cuibai Wei
20251

About S. Li

S. Li is a scholar working on Immunology, Pulmonary and Respiratory Medicine, Hematology, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 699 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (13 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Prostate Cancer Treatment and Research (3 papers), Neurological Disease Mechanisms and Treatments (3 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cerebrospinal fluid and hydrocephalus (1 paper). The work is most often cited by research in Immunology (569 citations), Dermatology (206 citations), Rheumatology (103 citations), Hematology (71 citations) and Physiology (99 citations). S. Li has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Yasmine Wasfi, B. Randazzo, Michael Song, Tsen‐Fang Tsai, L. Puig, Richard G. Langley, Susan Flavin, Jingzhi Jiang, Alexa B. Kimball and Kim Papp. Their work appears in journals such as British Journal of Dermatology, Annals of the Rheumatic Diseases, Annals of Oncology, Journal of the European Academy of Dermatology and Venereology and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey ZweegersBreakdown of academic impact, for papers by S.P. MentingBreakdown of academic impact, for papers by Miriam TeoliBreakdown of academic impact, for papers by Jeff GulcherBreakdown of academic impact, for papers by Perla LansangBreakdown of academic impact, for papers by Dafna GladmanBreakdown of academic impact, for papers by A. Howland HartleyBreakdown of academic impact, for papers by Drew J.B. KurtzmanBreakdown of academic impact, for papers by Alexander MarslandBreakdown of academic impact, for papers by Jason Coarse